[cid:image001.jpg@01D9874A.7C65B430]
Hello. I'm sending notification of the next MNN talk from my personal email address because of a technical glitch.
Our local speaker series continues FRIDAY MAY 19 with a talk from Dr. Mike Jackson. This presentation is IN-PERSON with a hybrid Zoom link provided for those who cannot make it. The information as follows:
MNN Seminar & Visiting Speaker Series
Friday May 19, 2023
9:00 AM
Dr. Mike Jackson
Associate Professor
Department of Pharmacology and Therapeutics
University of Manitoba
"How to disrupt excitotoxic cascades in Alzheimer's disease"
*IN-PERSON EVENT*
LOCATION: Bannatyne Campus, Apotex Building, Room 050
ZOOM LINK FOR OFF-CAMPUS ATTENDEES:
https://umanitoba.zoom.us/j/65215272385?pwd=a2NiYStpUnNJV0lCTWlPRzNVQ2pIdz09
Meeting ID: 652 1527 2385
Passcode: 642549
For bio, research profile & objectives, see attached.
For more information, please contact Dr. Tabrez Siddiqui, Tabrez.siddiqui(a)umanitoba.ca<mailto:Tabrez.siddiqui@umanitoba.ca>
To subscribe or unsubscribe to this mail list, click: https://lists.umanitoba.ca/mailman3/lists/neuro-all.lists.umanitoba.ca/
******************************************
[cid:image002.jpg@01D9874A.7C65B430]<http://www.manitobaneuroscience.ca/>
[cid:image003.png@01D9874A.7C65B430]<https://www.facebook.com/manitobaneuroscience/?fref=ts> [cid:image004.jpg@01D9874A.7C65B430] <https://www.instagram.com/manitobaneuroscience/> [cid:image005.png@01D9874A.7C65B430] <https://twitter.com/manitobaneuro>
Dear MNN Members,
To maximize the opportunity for trainees to submit their poster abstracts to the 2023 MNN Scientific Meeting (June 23 @ The Leaf), we have decided to extend the Abstract Submission Deadline to this Friday, May 19th. All trainees should ensure they are registered first before submitting their abstract. Please follow the link below for registration and abstract submission. Note that trainees who's abstracts are selected for short talks will be notified the week of May 22 with further details.
https://www.cpd-umanitoba.com/events/manitoba-neuroscience-network-mnn-2023/
As a reminder, the final deadline for registration only for the 2023 MNN Scientific Meeting is June 9th!
Thank you!
2023 MNN Planning Committee
Benjamin W. Lindsey, PhD (he/him)
Assistant Professor
Laboratory of Neural Stem Cell Plasticity & Regeneration
Department of Human Anatomy and Cell Science
Rady Faculty of Health Sciences
University of Manitoba
Website: www.lindseylab.ca<http://www.lindseylab.ca/>
Follow us on Twitter @LindseyLabGroup
Affiliated Member, Spinal Cord Research Center (SCRC), University of Manitoba
Adjunct Research Fellow, Australian Regenerative Medicine Institute, Monash University
Laboratory: 127 Basic Medical Sciences Building
Office: 128 Basic Medical Sciences Building
Office Phone: 204-789-3781
745 Bannatyne Avenue
Winnipeg, Manitoba, Canada, R3E 0J9
Benjamin.Lindsey(a)umanitoba.ca<mailto:Benjamin.Lindsey@umanitoba.ca>
The Dementia Journal Club led by Dr, Ben Albensi is featuring Dr. P.
Hemachandra Reddy from Texas Tech University. All are welcome. Information:
May 9th 11:00 AM Eastern Time (US and Canada)
https://nova.zoom.us/j/97537065873?pwd=clB6VWRpRjFhcFVpN3RuaVNxbzZJdz09
Meeting ID: 975 3706 5873
Passcode: 239509
Bio: P. Hemachandra Reddy, Ph.D., is the Tenured Professor and Vice Chair
Research of Basic and Translational Sciences Internal Medicine and Professor
of Pharmacology & Neuroscience, Neurology, Public Health and Speech,
Language and Hearing Departments at Texas Tech University Health Sciences
Center in Lubbock. Dr. Reddy is also an adjunct Professor of Nutritional
Sciences Department of Human Sciences at Texas Tech University, in Lubbock.
Dr. Reddy is an elected fellow of the American Neurological Association
(2014), and an elected Fellow of American Association for the Advancement of
Sciences (2020). Received Bharath Gaurav Award from Government of India
(2016). Dr. Reddy has published two Books with Elsevier - 1) Molecular
Biology of Aging in 2017 and 2) COVID-19 in Alzheimer's Disease and Dementia
in 2023. He was formerly an Executive Director and Chief Scientific Officer
of the Garrison Institute on Aging (2014-2019) and former Associate
Scientist (2009-2014) in the Division of Neuroscience at the Oregon National
Primate Research Center, affiliated with Oregon Health & Sciences
University. Dr. Reddy received his <http://b.sc/> B.Sc. and <http://m.sc/>
M.Sc. in biology from Sri Venkateswara University, Tirupati, India, and he
received an M. Phil in human cytogenetics from Delhi University. As a
commonwealth scholar (1990-1993), he was awarded a PhD (1994) in human
genetics from the University College, London. Dr. Reddy received
postdoctoral training (1995-2000) at the National Human Genome Research
Institute of the National Institutes of Health. He was a standing member of
the Veteran Affairs Merit Review Study Section (2007-2010), and NIH study
section, Neuronal Oxidative Metabolism and Death (2013-2019) and served on
several NIH study sections. He received funding from NIH since 2002.
Currently he is the principal investigator to 2 NIH R01 grants, 2 R56
grants. Dr. Reddy is the Co-inventor and Chief Scientific Officer of
Lubbock-based small business company, abSynapTEX, LLC. Recently, abSynapTEX,
LLC received an STTR award from NIH. Dr. Reddy is a prolific writer, author
or co-author of more than 260 peer-reviewed articles/chapters/reviews,
including publications in such journals as Nature Genetics, Redox Biology,
Aging Cell, Ageing Research Reviews, Trends in Neurosciences, Trends in
Molecular Medicine, Drug Discovery Today and Human Molecular Genetics. As
indicated on the Google Scholar website <https://lnkd.in/guXJZ2h8>
https://lnkd.in/guXJZ2h8 (accessed April, 2023, Google Scholar search), Dr.
Reddy's articles have received over 26,410 citations with an H-Index of 84
and an i10-Index of 179.